APA (7th ed.) Citation

Gómez, E., Montero, J. L., Molina, E., García‐Buey, L., Casado, M., Fuentes, J., . . . Londoño, M. (2024). Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice. Alimentary Pharmacology & Therapeutics, 59(12), 1604. https://doi.org/10.1111/apt.18004

Chicago Style (17th ed.) Citation

Gómez, E., et al. "Longitudinal Outcomes of Obeticholic Acid Therapy in Ursodiol‐nonresponsive Primary Biliary Cholangitis: Stratifying the Impact of Add‐on Fibrates in Real‐world Practice." Alimentary Pharmacology & Therapeutics 59, no. 12 (2024): 1604. https://doi.org/10.1111/apt.18004.

MLA (9th ed.) Citation

Gómez, E., et al. "Longitudinal Outcomes of Obeticholic Acid Therapy in Ursodiol‐nonresponsive Primary Biliary Cholangitis: Stratifying the Impact of Add‐on Fibrates in Real‐world Practice." Alimentary Pharmacology & Therapeutics, vol. 59, no. 12, 2024, p. 1604, https://doi.org/10.1111/apt.18004.